Schedule 13G ownership disclosure

Seelos Therapeutics Inc (US)

Common Stock · CUSIP: 81577F406

Event date: 2024-11-14

Filing-level shares
46,480.00
Percent of class
10.7%
  • Weber Mark

    Shares: 46,480.00 · Class: 10.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001310379-24-000002
Form type
SCHEDULE 13G
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Nov 25, 2024
Reporting period
Nov 14, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub